Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol + ropivacaine local infiltration for postoperative analgesia in day-case laparoscopic cholecystectomy
ChiCTR2400080338Phase 4Recruiting
- Sponsor
- Qionglai Medical Center Hospital
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Cholecystolithiasis and postoperative pain comparing Butorphanol + ropivacaine local infiltration with Ropivacaine alone local infiltration (2 arms). Primary endpoint: visual analogue scale for pain. Started Jan 2024; status: recruiting.
02
Drugs
butorphanolropivacaine
03
Conditions
Cholecystolithiasispostoperative pain
Beyond the preview
Go deeper on ChiCTR2400080338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080338.